Lapatinib Suppresses HER2-Overexpressed Cholangiocarcinoma and Overcomes ABCB1– Mediated Gemcitabine Chemoresistance
Zhiqing Bai(Jilin University), Jiahong Dong(Beijing Tsinghua Chang Gung Hospital)
Cited by 19
Related Papers
Co-administration of MDR1 and BCRP or EGFR/PI3K inhibitors overcomes lenvatinib resistance in hepatocellular carcinoma
|Frontiers in Oncology|2022|43
Programmed death ligand-1, tumor infiltrating lymphocytes and HLA expression in Chinese extrahepatic cholangiocarcinoma patients: Possible immunotherapy implications
|BioScience Trends|2019|27
Prostaglandin E2-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarcinoma
|Signal Transduction and Targeted Therapy|2026|0